Sepsis: a new application for the SUL-compounds?

Sulfateq B.V. is dedicated to developing new drugs for several diseases: Acute Kidney Injury (AKI), Chronic Obstructive Pulmonary Disease (COPD),  Type II Diabetes (T2D) and obesity. We can now proudly announce that the SUL-compounds are being tested in sepsis, which is a disease that is characterized by a life-threatening response of the host to an …

Lees meer

New publications ROKEPIE

Lately there is a lot of happening at Sulfateq which is very positive for the development of ROKEPIE. Besides our new website there are also multiple publications and papers which have been published or will be published in the near future. What’s even greater is that all of these publications show the strength of ROKEPIE and …

Lees meer

BIO-Europe 2016 – Cologne

From 7 till 9 November 2016 we will be attending BIO-Europe 2016 in Cologne (Germany). BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. Our CEO Kees van der Graaf will be present on these days to talk about business opportunities. Our main focus will be the prevention of Acute Kidney Injury with …

Lees meer

The Sulfateq compound SUL-121 is proven to potentially contribute to the treatment of COPD

We are proud to announce that one of our SUL-compounds, SUL-121, is proven to have both an anti-inflammatory and bronchodilating effect in vitro and in vivo. In the study, performed by the University of Groningen, the researchers explored the anti-inflammatory and bronchodilating properties of the novel pharmacological compound SUL-121 in vitro and in vivo. Their conclusion is that …

Lees meer

TEDx talk | Prof. Henning about the foundation of our company: Hibernation and Human medicine

On November 20th last year, Prof. Dr. R.H. Henning from the University of Groningen, the Netherlands, gave an interesting TEDx talk about hibernation and its importance for human medicine. TEDx Groningen just recently released the video of this inspiring talk “Is human hibernation possible”. Sulfateq BV has a close working relationship with the University of …

Lees meer